Henn Matthew R.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$2.49M

Insider Activity of Henn Matthew R.

According to the SEC Form 4 filings, Henn Matthew R., being in a position of

  1. See Remarks at Seres Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 9870 shares for $11,363,
    over all time since 2020-12-01, has bought 0 shares, and sold 101682 shares for $2.49M.

The largest sale of all time was on 2020-12-01 and amounted to 91812 shares of Seres Therapeutics, Inc. for $2.48M.

Biography of Henn Matthew R.

No biography is available at this moment.

2024-08-16SaleSeres Therapeutics, Inc.
MCRB
See Remarks
923
0.0006%
$0.84$7750%
2024-05-15SaleSeres Therapeutics, Inc.
MCRB
See Remarks
891
0.0006%
$0.94$838-3.98%
2024-02-16SaleSeres Therapeutics, Inc.
MCRB
See Remarks
4,170
0.0033%
$1.08$4,504-13.67%
2023-10-30SaleSeres Therapeutics, Inc.
MCRB
See Remarks
3,886
0.0028%
$1.35$5,246-29.66%
2020-12-01SaleSeres Therapeutics, Inc.
MCRB
See Remarks
91,812
0.1181%
$27.04$2.48M-22.88%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.